Stay updated on Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedUpdates to the study record history page include a new Revision: v3.6.0 and removal of the previous v3.5.5 label. In addition, the page now presents a 'Check who can join' option and a 'Find Contact Information' link to assist potential participants in assessing eligibility and contacting the study team.SummaryDifference0.5%

- Check21 days agoChange DetectedThe study history now marks SPARTAN as Recruiting and updates the page to reflect current enrollment. It also adds key sections such as Contacts/Locations, Eligibility, Study Design, Study Description, Study Status, Study Identification, and Recruitment Status, replacing the older 'Active, not recruiting' label and the previous trial title wording.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry v3.5.4 is added to the record history, updating the study's version history. The previous revision v3.5.3 is removed from the list.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s footer updates the ClinicalTrials.gov build/release revision from **v3.5.2** to **v3.5.3**, indicating a web/version update. No study-specific content or record-history details are altered.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 to the history. Removed Revision: v3.5.0.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the Record History.SummaryDifference0.1%

Stay in the know with updates to Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.